Kathryn Effendi

1.0k total citations
23 papers, 766 citations indexed

About

Kathryn Effendi is a scholar working on Oncology, Molecular Biology and Hepatology. According to data from OpenAlex, Kathryn Effendi has authored 23 papers receiving a total of 766 indexed citations (citations by other indexed papers that have themselves been cited), including 11 papers in Oncology, 10 papers in Molecular Biology and 8 papers in Hepatology. Recurrent topics in Kathryn Effendi's work include Hepatocellular Carcinoma Treatment and Prognosis (6 papers), Liver Disease Diagnosis and Treatment (6 papers) and Cancer Immunotherapy and Biomarkers (3 papers). Kathryn Effendi is often cited by papers focused on Hepatocellular Carcinoma Treatment and Prognosis (6 papers), Liver Disease Diagnosis and Treatment (6 papers) and Cancer Immunotherapy and Biomarkers (3 papers). Kathryn Effendi collaborates with scholars based in Japan, Belgium and Indonesia. Kathryn Effendi's co-authors include Michiie Sakamoto, Yohei Masugi, Ken Yamazaki, Hanako Tsujikawa, Yuko Kitagawa, Taisuke Mori, Osamu Itano, Wenlin Du, Minoru Tanabe and Minoru Kitago and has published in prestigious journals such as SHILAP Revista de lepidopterología, Hepatology and Clinical Cancer Research.

In The Last Decade

Kathryn Effendi

21 papers receiving 761 citations

Peers

Kathryn Effendi

HEPAT

ONCOL

EPIDE

M. Wu China

Emanuela Balladore Italy

Di‐Peng Ou China

Chang‐Jun Tan China

Zuo‐Lin Xiang China

Jacinth Wing‐Sum Cheu Hong Kong

Feiguo Zhou China

Deborah Lehrer United States

Oriol Arpí Spain

Shin-ichi Aishima Japan

M. Wu China

Kathryn Effendi

377 ×1.1

298 ×1.1

HEPAT

183 ×0.8

ONCOL

279 ×1.4

181 ×1.0

EPIDE

Citations per year, relative to Kathryn Effendi Kathryn Effendi (= 1×) peers M. Wu

Countries citing papers authored by Kathryn Effendi

Since Specialization

Citations

This map shows the geographic impact of Kathryn Effendi's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Kathryn Effendi with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Kathryn Effendi more than expected).

Fields of papers citing papers by Kathryn Effendi

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Kathryn Effendi. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Kathryn Effendi. The network helps show where Kathryn Effendi may publish in the future.

Co-authorship network of co-authors of Kathryn Effendi

This figure shows the co-authorship network connecting the top 25 collaborators of Kathryn Effendi. A scholar is included among the top collaborators of Kathryn Effendi based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Kathryn Effendi. Kathryn Effendi is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

Kurebayashi, Yutaka, Katsutoshi Sugimoto, Hanako Tsujikawa, et al.. (2024). Spatial Dynamics of T- and B-Cell Responses Predicts Clinical Outcome of Resectable and Unresectable Hepatocellular Carcinoma. Clinical Cancer Research. 30(24). 5666–5680. 7 indexed citations

Effendi, Kathryn. (2023). More than just a name: "nonalcoholic fatty liver disease (NAFLD)" versus "metabolic associated fatty liver disease (MAFLD)". SHILAP Revista de lepidopterología. 42(2). 119–120. 1 indexed citations

Kurebayashi, Yutaka, Akihisa Ueno, Hanako Tsujikawa, et al.. (2021). Immunovascular classification of HCC reflects reciprocal interaction between immune and angiogenic tumor microenvironments. Hepatology. 75(5). 1139–1153. 61 indexed citations

Effendi, Kathryn, Ken Yamazaki, Naoto Kubota, et al.. (2020). Telomerase reverse transcriptase (TERT) promoter mutation correlated with intratumoral heterogeneity in hepatocellular carcinoma. Pathology International. 70(9). 624–632. 13 indexed citations

Masugi, Yohei, Tokiya Abe, Hanako Tsujikawa, et al.. (2017). Quantitative assessment of liver fibrosis reveals a nonlinear association with fibrosis stage in nonalcoholic fatty liver disease. Hepatology Communications. 2(1). 58–68. 46 indexed citations

Sakamoto, Michiie, Hanako Tsujikawa, Kathryn Effendi, et al.. (2016). Pathological findings of nonalcoholic steatohepatitis and nonalcoholic fatty liver disease. Pathology International. 67(1). 1–7. 22 indexed citations

Masugi, Yohei, Ken Yamazaki, Katsura Emoto, et al.. (2015). Upregulation of integrin β4 promotes epithelial–mesenchymal transition and is a novel prognostic marker in pancreatic ductal adenocarcinoma. Laboratory Investigation. 95(3). 308–319. 69 indexed citations

Masugi, Yohei, Keiji Tanese, Katsura Emoto, et al.. (2015). Overexpression of adenylate cyclase‐associated protein 2 is a novel prognostic marker in malignant melanoma. Pathology International. 65(12). 627–634. 18 indexed citations

Effendi, Kathryn, Ken Yamazaki, Mariko Fukuma, & Michiie Sakamoto. (2014). Overexpression of Leucine-Rich Repeat-Containing G Protein-Coupled Receptor 5 (LGR5) Represents a Typical Wnt/β-Catenin Pathway-Activated Hepatocellular Carcinoma. Liver Cancer. 3(3-4). 451–457. 13 indexed citations

10.

Yamazaki, Ken, Yohei Masugi, Kathryn Effendi, et al.. (2014). Upregulated SMAD3 promotes epithelial–mesenchymal transition and predicts poor prognosis in pancreatic ductal adenocarcinoma. Laboratory Investigation. 94(6). 683–691. 57 indexed citations

11.

Ueno, Akihisa, Yohei Masugi, Ken Yamazaki, et al.. (2014). OATP1B3 expression is strongly associated with Wnt/β-catenin signalling and represents the transporter of gadoxetic acid in hepatocellular carcinoma. Journal of Hepatology. 61(5). 1080–1087. 115 indexed citations

12.

Emoto, Katsura, Yohei Masugi, Ken Yamazaki, et al.. (2013). Presence of primary cilia in cancer cells correlates with prognosis of pancreatic ductal adenocarcinoma. Human Pathology. 45(4). 817–825. 41 indexed citations

13.

Effendi, Kathryn, Ken Yamazaki, Taisuke Mori, et al.. (2012). Involvement of hepatocellular carcinoma biomarker, cyclase-associated protein 2 in zebrafish body development and cancer progression. Experimental Cell Research. 319(1). 35–44. 23 indexed citations

14.

Fukuma, Mariko, Keiji Tanese, Kathryn Effendi, et al.. (2012). Leucine-rich repeat-containing G protein-coupled receptor 5 regulates epithelial cell phenotype and survival of hepatocellular carcinoma cells. Experimental Cell Research. 319(3). 113–121. 39 indexed citations

15.

Kawakami, Takao, Kathryn Effendi, Ken Yamazaki, et al.. (2011). Identification by Differential Tissue Proteome Analysis of Talin-1 as a Novel Molecular Marker of Progression of Hepatocellular Carcinoma. Oncology. 80(5-6). 406–415. 44 indexed citations

16.

Yamazaki, Ken, Yohei Masugi, Taisuke Mori, et al.. (2010). Reduced transforming growth factor-β receptor II expression in hepatocellular carcinoma correlates with intrahepatic metastasis. Laboratory Investigation. 90(9). 1339–1345. 50 indexed citations

17.

Effendi, Kathryn & Michiie Sakamoto. (2010). Molecular Pathology in Early Hepatocarcinogenesis. Oncology. 78(2). 157–160. 18 indexed citations

18.

Sakamoto, Maki, Kathryn Effendi, & Yohei Masugi. (2010). Molecular Diagnosis of Multistage Hepatocarcinogenesis. Japanese Journal of Clinical Oncology. 40(9). 891–896. 35 indexed citations

19.

Effendi, Kathryn, Taisuke Mori, Mina Komuta, et al.. (2009). Bmi‐1 gene is upregulated in early‐stage hepatocellular carcinoma and correlates with ATP‐binding cassette transporter B1 expression. Cancer Science. 101(3). 666–672. 45 indexed citations

20.

Sakamoto, Michiie, Taisuke Mori, Yohei Masugi, et al.. (2008). Candidate Molecular Markers for Histological Diagnosis of Early Hepatocellular Carcinoma. Intervirology. 51(Suppl. 1). 42–45. 38 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact